Trial of an Intervention to Improve Acute Heart Failure Outcomes
- PMID: 36342109
- DOI: 10.1056/NEJMoa2211680
Trial of an Intervention to Improve Acute Heart Failure Outcomes
Abstract
Background: Patients with acute heart failure are frequently or systematically hospitalized, often because the risk of adverse events is uncertain and the options for rapid follow-up are inadequate. Whether the use of a strategy to support clinicians in making decisions about discharging or admitting patients, coupled with rapid follow-up in an outpatient clinic, would affect outcomes remains uncertain.
Methods: In a stepped-wedge, cluster-randomized trial conducted in Ontario, Canada, we randomly assigned 10 hospitals to staggered start dates for one-way crossover from the control phase (usual care) to the intervention phase, which involved the use of a point-of-care algorithm to stratify patients with acute heart failure according to the risk of death. During the intervention phase, low-risk patients were discharged early (in ≤3 days) and received standardized outpatient care, and high-risk patients were admitted to the hospital. The coprimary outcomes were a composite of death from any cause or hospitalization for cardiovascular causes within 30 days after presentation and the composite outcome within 20 months.
Results: A total of 5452 patients were enrolled in the trial (2972 during the control phase and 2480 during the intervention phase). Within 30 days, death from any cause or hospitalization for cardiovascular causes occurred in 301 patients (12.1%) who were enrolled during the intervention phase and in 430 patients (14.5%) who were enrolled during the control phase (adjusted hazard ratio, 0.88; 95% confidence interval [CI], 0.78 to 0.99; P = 0.04). Within 20 months, the cumulative incidence of primary-outcome events was 54.4% (95% CI, 48.6 to 59.9) among patients who were enrolled during the intervention phase and 56.2% (95% CI, 54.2 to 58.1) among patients who were enrolled during the control phase (adjusted hazard ratio, 0.95; 95% CI, 0.92 to 0.99). Fewer than six deaths or hospitalizations for any cause occurred in low- or intermediate-risk patients before the first outpatient visit within 30 days after discharge.
Conclusions: Among patients with acute heart failure who were seeking emergency care, the use of a hospital-based strategy to support clinical decision making and rapid follow-up led to a lower risk of the composite of death from any cause or hospitalization for cardiovascular causes within 30 days than usual care. (Funded by the Ontario SPOR Support Unit and others; COACH ClinicalTrials.gov number, NCT02674438.).
Copyright © 2022 Massachusetts Medical Society.
Comment in
-
Implementing an earlier and more intensive follow-up in acute heart failure: the STRONG-HF and COACH trials.Nat Rev Cardiol. 2023 Apr;20(4):213-214. doi: 10.1038/s41569-023-00841-x. Nat Rev Cardiol. 2023. PMID: 36747103 No abstract available.
-
Teamwork in Acute Heart Failure: The Role of the Cardiac Anesthesiologist.J Cardiothorac Vasc Anesth. 2023 Jun;37(6):843-845. doi: 10.1053/j.jvca.2023.01.024. Epub 2023 Feb 2. J Cardiothorac Vasc Anesth. 2023. PMID: 36842940 No abstract available.
-
In acute HF in the ED, a risk-based management algorithm vs. usual care reduced a composite clinical outcome at 30 d.Ann Intern Med. 2023 Mar;176(3):JC31. doi: 10.7326/J23-0004. Epub 2023 Mar 7. Ann Intern Med. 2023. PMID: 36877971
-
Improving care for heart failure patients by COACHing clinicians to use decision-support tools.Eur Heart J. 2023 Apr 21;44(16):1392-1393. doi: 10.1093/eurheartj/ehad097. Eur Heart J. 2023. PMID: 36924190 No abstract available.
-
Trial of an Intervention to Improve Acute Heart Failure Outcomes.N Engl J Med. 2023 Mar 30;388(13):e46. doi: 10.1056/NEJMc2301251. N Engl J Med. 2023. PMID: 36988606 No abstract available.
-
Trial of an Intervention to Improve Acute Heart Failure Outcomes.N Engl J Med. 2023 Mar 30;388(13):e46. doi: 10.1056/NEJMc2301251. N Engl J Med. 2023. PMID: 36988607 No abstract available.
-
Trial of an Intervention to Improve Acute Heart Failure Outcomes. Reply.N Engl J Med. 2023 Mar 30;388(13):e46. doi: 10.1056/NEJMc2301251. N Engl J Med. 2023. PMID: 36988608 No abstract available.
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical